EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tamoxifen induces region-specific osteocytic recombination and transiently alters bone structure in Dmp1-Cre-ERT2 mice

Natalie Yy Koh, Natalie Ky Wee, Narelle E McGregor, Ingrid J Poulton, Milana Kuropatkina, Christa Maes, Natalie A Sims

Journal of Biological Chemistry · 2026-08 · 302 (8) · 113275

DOI: 10.1016/j.jbc.2026.113275 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2026-08. Verfasst von Natalie Yy Koh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Bone Cell Biology and Disease Unit, St Vincent's Institute of Medical Research, Fitzroy, Melbourne, Australia; Department of Medicine at St Vincent's…. Hauptthemen laut MEDLINE: Tamoxifen, Osteocytes, Recombination, Genetic, Integrases. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, KU Leuven, The University of Melbourne.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tamoxifen is widely used to activate Cre-ERT2/LoxP transgenic systems for cell- and time-specific gene recombination. However, its regional and long-term effects on the adult murine skeleton are not well defined. Here we sought to identify immediate and long-term regional effects of short-term tamoxifen treatment on gene recombination and cortical and trabecular bone structure in young adult 10kb Dmp1-Cre-ERT2 mice, which targets gene recombination primarily to osteoblasts and osteocytes. Tamoxifen was administered by four 20mg/kg bolus injections to 12-week-old mice of both sexes. In cortical bone, tamoxifen induced persistent recombination in osteocytes (detected by Ai9.tdTomato labelling), which was region- and sex-dependent: female metaphyseal cortex showed the highest labelling (in ∼80% of osteocytes) that remained for 12 weeks. However, diaphyseal cortex and males showed less osteocyte labelling (∼60%). In trabecular bone of male and female mice, labelling was observed in ∼90% of osteocytes and in ∼60% of bone surface cells at 14 weeks of age but both substantially after a further twelve weeks, particularly in females. In both sexes, tamoxifen transiently accelerated longitudinal bone growth, increased trabecular bone mass, and increased metaphyseal cortical porosity while suppressing radial growth. Bone structure largely normalised by 26 weeks, but the osteocyte lacunocanalicular network remained disordered. This indicates that (i) 10kb Dmp1-Cre-ERT2-induced recombination is not uniform through the skeleton or between sexes, and (ii) short-term tamoxifen administration has both transient and persistent effects on bone structure. Investigators using any tamoxifen-inducible system should test recombination in each site and sex, and control for tamoxifen's effects on skeletal structure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TamoxifenOsteocytesRecombination, GeneticIntegrasesExtracellular Matrix ProteinsBone and BonesAnimalsFemaleMiceMaleMice, Transgenic

Stichwörter der Autor:innen

boneestrogen receptorosteoblastosteocyterecombinationsex differencestransgenic mice

Substanzen

TamoxifenDmp1 protein, mouseIntegrasesExtracellular Matrix ProteinsCre recombinase

Autor:innen und Institutionen

  • Bone Cell Biology and Disease Unit, St Vincent's Institute of Medical Research, Fitzroy, Melbourne, Australia; Department of Medicine at St Vincent's Hospital, The University of Melbourne, Melbourne, Australia; Laborato…
  • Bone Cell Biology and Disease Unit, St Vincent's Institute of Medical Research, Fitzroy, Melbourne, Australia; Department of Medicine at St Vincent's Hospital, The University of Melbourne, Melbourne, Australia.
  • Bone Cell Biology and Disease Unit, St Vincent's Institute of Medical Research, Fitzroy, Melbourne, Australia.
  • Laboratory of Skeletal Cell Biology and Physiology (SCEBP), Skeletal Biology and Engineering Research Center (SBE), Department of Development and Regeneration, KU Leuven, Leuven, Belgium.
  • Bone Cell Biology and Disease Unit, St Vincent's Institute of Medical Research, Fitzroy, Melbourne, Australia; Department of Medicine at St Vincent's Hospital, The University of Melbourne, Melbourne, Australia; Mary Mac…

Förderung

  • National Health and Medical Research Council
  • KU Leuven
  • The University of Melbourne

Zitieren

APA

Koh, N. Y., Wee, N. K., McGregor, N. E., Poulton, I. J., Kuropatkina, M., Maes, C., & Sims, N. A. (2026). Tamoxifen induces region-specific osteocytic recombination and transiently alters bone structure in Dmp1-Cre-ERT2 mice. Journal of Biological Chemistry, 302(8), 113275. https://doi.org/10.1016/j.jbc.2026.113275

Vancouver

Koh NY, Wee NK, McGregor NE, Poulton IJ, Kuropatkina M, Maes C, et al. Tamoxifen induces region-specific osteocytic recombination and transiently alters bone structure in Dmp1-Cre-ERT2 mice. Journal of Biological Chemistry. 2026;302(8):113275. doi:10.1016/j.jbc.2026.113275

BibTeX
@article{Koh2026,
  author = {Koh, Natalie Yy and Wee, Natalie Ky and McGregor, Narelle E and Poulton, Ingrid J and Kuropatkina, Milana and Maes, Christa and Sims, Natalie A},
  title = {Tamoxifen induces region-specific osteocytic recombination and transiently alters bone structure in Dmp1-Cre-ERT2 mice},
  journal = {Journal of Biological Chemistry},
  year = {2026},
  volume = {302},
  number = {8},
  pages = {113275},
  doi = {10.1016/j.jbc.2026.113275}
}
Kostenlos starten →